TLC599

· Taiwan Liposome Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TLC599, covering 2022-05-06 to 2024-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee [Phase 2]